Paul J. Mellett - Jun 17, 2022 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Treasurer and CFO
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Stock symbol
ENTA
Transactions as of
Jun 17, 2022
Transactions value $
$40,960
Form type
4
Date filed
6/21/2022, 04:01 PM
Previous filing
Feb 15, 2022
Next filing
Nov 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Options Exercise $41K +3.48K +5.99% $11.77 61.6K Jun 17, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (right to buy) Options Exercise $0 -3.48K -100% $0.00* 0 Jun 17, 2022 Common Stock 3.48K $11.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option are fully vested and exercisable.